Gloves Come Off In Plavix Battle

By Lindsay Fortado

Law360, New York (August 18, 2006, 12:00 AM ET) -- Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.

In court filings, Apotex said it had alerted the Federal Trade Commission to attempts by a Bristol-Myers executive to mislead the government about secret agreements the pharmaceutical giant made with Apotex.

The side deals included two provisions that were not part of the original settlement agreement that said Bristol-Myers and Sanofi would give Apotex a six-month head start...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles